Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail

Ayse Ece Cali Daylan; Balazs Halmos

doi:10.21037/tlcr-23-245

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail

Ayse Ece Cali Daylan
, Balazs Halmos

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1636-1642
Number of pages	7
Journal	Translational Lung Cancer Research
Volume	12
Issue number	7
DOIs	https://doi.org/10.21037/tlcr-23-245
State	Published - Jul 2023

Keywords

Immunotherapy
metastatic
non-small cell lung cancer (NSCLC)
pembrolizumab

Access to Document

10.21037/tlcr-23-245

Cite this

@article{8760a468b0364ba0a73dae9299b838b0,

title = "Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail",

keywords = "Immunotherapy, metastatic, non-small cell lung cancer (NSCLC), pembrolizumab",

author = "Daylan, \{Ayse Ece Cali\} and Balazs Halmos",

year = "2023",

month = jul,

doi = "10.21037/tlcr-23-245",

language = "English",

volume = "12",

pages = "1636--1642",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

number = "7",

}

TY - JOUR

T1 - Long-term benefit of immunotherapy in metastatic non-small cell lung cancer

T2 - the tale of the tail

AU - Daylan, Ayse Ece Cali

AU - Halmos, Balazs

PY - 2023/7

Y1 - 2023/7

KW - Immunotherapy

KW - metastatic

KW - non-small cell lung cancer (NSCLC)

KW - pembrolizumab

UR - https://www.scopus.com/pages/publications/85169041034

U2 - 10.21037/tlcr-23-245

DO - 10.21037/tlcr-23-245

M3 - Comment/debate

C2 - 37577318

AN - SCOPUS:85169041034

SN - 2218-6751

VL - 12

SP - 1636

EP - 1642

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

IS - 7

ER -

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail

Keywords

Access to Document

Other files and links

Cite this